qSOFA Score: Bedside Sepsis Assessment Guide for Clinicians

The quick Sequential Organ Failure Assessment (qSOFA) is a bedside clinical tool introduced alongside the Sepsis-3 definitions by Seymour CW et al. in JAMA in 2016 (JAMA 2016;315:762-774). It was designed as a simple, rapid assessment to identify patients outside the ICU who may have infection-related organ dysfunction — the defining feature of sepsis under the Sepsis-3 framework.

Critically, qSOFA is not a sepsis screening tool in the traditional sense. It does not diagnose sepsis, and it was never intended to replace clinical judgment or comprehensive sepsis evaluation. The Surviving Sepsis Campaign and the Sepsis-3 task force have explicitly stated that qSOFA should be used as a prompt for clinicians to consider the possibility of sepsis and to investigate further — not as a standalone diagnostic criterion.

This distinction matters in practice. A patient with a qSOFA score of 0 may still have sepsis. A patient with a qSOFA score of 2 may have organ dysfunction from a non-infectious cause. The score is a bedside signal that, when positive, should trigger a more thorough assessment including infection workup and, where appropriate, the full SOFA score to confirm organ dysfunction.

qSOFA consists of three clinical parameters, each scored as 0 (absent) or 1 (present), for a maximum score of 3. All three can be assessed at the bedside in under a minute without any laboratory tests or imaging.

Respiratory rate ≥22 breaths per minute (1 point): Tachypnea is an early sign of physiological stress and respiratory compensation for metabolic acidosis. In the context of suspected infection, elevated respiratory rate may reflect the increased metabolic demand of systemic inflammation or early acute respiratory distress.

Altered mentation (1 point): Any acute change in mental status from the patient's baseline — confusion, disorientation, somnolence, agitation, or reduced GCS below 15. This component captures the neurological impact of sepsis-related organ dysfunction and hypoperfusion.

Systolic blood pressure ≤100 mmHg (1 point): Hypotension reflects cardiovascular compromise, which in the context of infection may indicate sepsis-induced vasodilation, myocardial depression, or inadequate intravascular volume.

The simplicity of qSOFA is intentional. Unlike the full SOFA score, which requires laboratory values (bilirubin, creatinine, platelet count, PaO2/FiO2 ratio) and detailed clinical data (vasopressor administration, GCS), qSOFA uses only vital signs and mental status — data available at the bedside or in triage without delay.

A qSOFA score of ≥2 (two or more of the three criteria present) identifies patients with suspected infection who have an increased risk of poor outcomes, including prolonged ICU stay and in-hospital mortality. In the original derivation cohort, patients with a qSOFA ≥2 outside the ICU had a 3- to 14-fold increase in in-hospital mortality compared to those with a score of 0 or 1.

When a patient with suspected or confirmed infection has a qSOFA ≥2, clinicians should consider the following actions: initiate or escalate sepsis workup (blood cultures, lactate, urinalysis, imaging as indicated), assess for organ dysfunction using the full SOFA score if available, initiate empiric antibiotics within the recommended time window if sepsis is likely, consider fluid resuscitation and hemodynamic support, and escalate the level of care (ICU consultation or transfer if appropriate).

A qSOFA of 0 or 1 does not exclude sepsis. This is a critical limitation: the tool has relatively low sensitivity for early sepsis detection, meaning it may not trigger in patients with early-stage infection who have not yet developed significant organ dysfunction. Physicians should maintain clinical suspicion for sepsis based on the overall clinical picture, regardless of the qSOFA score.

The practical value of qSOFA is in its specificity and prognostic power: when the score is elevated in a patient with infection, it is a strong signal that the patient is deteriorating or at high risk of deterioration, and should prompt immediate clinical attention.

Understanding the relationship between qSOFA, SOFA, and SIRS requires understanding the evolution of sepsis definitions.

SIRS (Systemic Inflammatory Response Syndrome) criteria — temperature >38°C or <36°C, heart rate >90, respiratory rate >20, WBC >12,000 or <4,000 — were the foundation of sepsis identification for over two decades (Sepsis-1 and Sepsis-2 definitions). SIRS is highly sensitive but poorly specific: up to 50% of hospitalized ward patients meet SIRS criteria at some point during their admission, many without infection or significant clinical deterioration.

SOFA (Sequential Organ Failure Assessment) is a comprehensive scoring system that quantifies organ dysfunction across six systems: respiratory (PaO2/FiO2), coagulation (platelets), liver (bilirubin), cardiovascular (MAP and vasopressors), central nervous system (GCS), and renal (creatinine and urine output). Under Sepsis-3, sepsis is defined as a suspected infection with an acute change of ≥2 SOFA points. SOFA provides the most rigorous assessment of organ dysfunction but requires laboratory data that may not be immediately available.

qSOFA was developed as a simplified bedside proxy that identifies patients who warrant full SOFA assessment. It is not a replacement for SOFA and does not define sepsis — it identifies patients at risk who should be evaluated more thoroughly.

In practice, these tools serve complementary roles. SIRS remains useful as a screening trigger (high sensitivity catches early infection), qSOFA adds prognostic discrimination at the bedside (identifying higher-risk patients), and SOFA provides the definitive assessment of organ dysfunction for sepsis diagnosis and severity quantification.

qSOFA is most useful in specific clinical contexts, and understanding its limitations is as important as knowing when to apply it.

Best applications: Ward patients with suspected infection where rapid bedside assessment is needed. Emergency department triage to identify patients who may need expedited care. Resource-limited settings where laboratory testing is delayed or unavailable. Serial assessment to detect clinical trajectory — a rising qSOFA over hours suggests deterioration.

Key limitations: Low sensitivity for early sepsis detection means that many patients with early sepsis will have a qSOFA of 0 or 1. Studies have consistently shown that qSOFA misses approximately 25–50% of patients who meet Sepsis-3 criteria, depending on the population studied. This makes it unsuitable as a standalone sepsis screening tool in settings where early detection is the priority.

For early sepsis detection, many institutions use multi-parameter electronic warning systems (NEWS2, MEWS) or SIRS-based screening protocols, reserving qSOFA as an additional assessment that adds prognostic information when positive. The Surviving Sepsis Campaign 2021 guidelines recommend against using qSOFA as a single screening tool for sepsis, favoring instead screening tools with higher sensitivity.

The clinical lesson is clear: qSOFA is a specificity-oriented tool that excels at identifying patients who are likely to deteriorate, not a sensitivity-oriented tool for catching every case of early sepsis. Clinicians should use it alongside — not instead of — clinical judgment and institutional screening protocols.

Integrating qSOFA effectively into clinical practice means understanding where it fits within the broader sepsis assessment framework.

At first contact with a patient with suspected infection — whether in the ED, on the ward, or in the outpatient setting — assess the three qSOFA parameters as part of your initial vital signs and clinical assessment. This takes less than 60 seconds and requires no additional resources.

If qSOFA is ≥2, treat this as a clinical escalation trigger. Initiate the sepsis workup immediately: blood cultures before antibiotics, serum lactate, and a focused assessment of potential infection sources. Begin empiric antibiotics within one hour if sepsis is suspected. Consider the need for fluid resuscitation and reassess hemodynamics after the initial bolus. Notify the ICU team or rapid response team if the patient is on a general ward.

If qSOFA is 0 or 1, do not assume the patient is safe. Maintain clinical vigilance, particularly if other features raise concern — elevated lactate, high fever, focal infection signs, immunocompromise, or recent hospitalization. Serial reassessment of qSOFA at regular intervals (every 4–6 hours, or with any clinical change) can detect evolving deterioration.

Document the qSOFA score and its components in the clinical record. This creates a timestamped record of clinical status that supports handover communication, trend analysis, and retrospective review.

Clinical decision support platforms like AttendMe.ai integrate the qSOFA calculator alongside the SOFA and SIRS calculators, enabling rapid calculation and comparison. When a clinical question involves sepsis assessment, the relevant calculators are automatically detected and presented with current evidence on sepsis management, creating a seamless workflow from assessment to evidence-informed action.